{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:40:18Z","timestamp":1788108018898,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cld.2012.03.009","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T04:22:02Z","timestamp":1335327722000},"page":"301-320","source":"Crossref","is-referenced-by-count":73,"title":["Hepatic Encephalopathy"],"prefix":"10.1016","volume":"16","author":[{"given":"Vandana","family":"Khungar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Poordad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2012.03.009_bib1","unstructured":"Voight M, Conn H. Hepatic encephalopathy. In: Robson SC, Trey C, Kirsch RE (editors). Diagnosis and management of liver disease. Chapman & Hall, London, p. 140\u2013147, Chapter 13."},{"issue":"4","key":"10.1016\/j.cld.2012.03.009_bib2","first-page":"222","article-title":"Current concepts in the pathophysiology and management of hepatic encephalopathy","volume":"7","author":"Frederick","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy \u2013 definition, nomenclature, diagnosis and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.03.009_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1746-6342.2006.03215.x","article-title":"Review article: the burden of hepatic encephalopathy","volume":"25","author":"Poordad","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.03.009_bib5","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1111\/j.1572-0241.2001.04130.x","article-title":"Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy","volume":"96","author":"Romero-Gomez","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2010.08.061","article-title":"Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy","volume":"140","author":"Bajaj","year":"2011","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cld.2012.03.009_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMe1000850","article-title":"Gut flora and hepatic encephalopathy in patients with cirrhosis","volume":"362","author":"Riordan","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.009_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"Leevy","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2012.03.009_bib10","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jclinepi.2009.06.014","article-title":"Short-form Zarit caregiver burden interviews were valid in advanced conditions","volume":"63","author":"Higginson","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cld.2012.03.009_bib12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.03.009_bib14","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0168-8278(10)60152-3","article-title":"Severity of chronic cognitive impairment in cirrhosis increases with number of episodes of overt hepatic encephalopathy","volume":"52","author":"Bajaj","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2012.03.009_bib15","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.009_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcrc.2009.01.008","article-title":"Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy","volume":"24","author":"Fichet","year":"2009","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.cld.2012.03.009_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(55)90422-0","article-title":"Summer skill WH. Blood-ammonium levels in liver disease and hepatic coma","volume":"268","author":"Phear","year":"1955","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2012.03.009_bib18","series-title":"The hepatic coma syndromes and lactulose","author":"Conn","year":"1979"},{"key":"10.1016\/j.cld.2012.03.009_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/jhep.2002.36497","article-title":"Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS","volume":"36","author":"Olde Damink","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jhep.2004.03.021","article-title":"Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy","volume":"41","author":"Romero-Gomez","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-8278(85)80063-5","article-title":"Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle","volume":"1","author":"Haussinger","year":"1985","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ki.1986.9","article-title":"Regulation of glutamine metabolism in dog kidney in\u00a0vivo","volume":"29","author":"Vinay","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.cld.2012.03.009_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1172\/JCI110436","article-title":"Renal ammoniagenesis in an early stage of metabolic acidosis in man","volume":"69","author":"Tizianello","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2012.03.009_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000415707","article-title":"Renal ammoniagenesis during the adaptation to metabolic acidosis in man","volume":"63","author":"Tizianello","year":"1988","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.cld.2012.03.009_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1053\/jhep.2003.50221","article-title":"The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis","volume":"37","author":"Olde Damink","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(97)07373-X","article-title":"Cerebral edema and increased intracranial pressure in chronic liver disease","volume":"351","author":"Donovan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2012.03.009_bib27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cgh.2008.04.020","article-title":"Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient","volume":"6","author":"Kavitt","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4615-5945-0_7","article-title":"The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy","volume":"420","author":"Norenberg","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cld.2012.03.009_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0140-6736(90)91594-Z","article-title":"\u201cEndogenous\u201d benzodiazepine activity in body fluids of patients with hepatic encephalopathy","volume":"336","author":"Mullen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2012.03.009_bib30","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/brain\/awn209","article-title":"Brain cholinergic impairment in liver failure","volume":"131","author":"Garcia-Ayllon","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.cld.2012.03.009_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.acthis.2010.01.009","article-title":"Acetylcholinesterase activity in an experimental rat model of type C hepatic encephalopathy","volume":"113","author":"Mendez","year":"2011","journal-title":"Acta Histochem"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.03.009_bib32","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0168-8278(10)60154-7","article-title":"Transdermal rivastigmine for treatment of encephalopathy in liver cirrhosis \u2013 a randomized placebo controlled trial (TREC TRIAL)","volume":"52","author":"Basu","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib33","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib34","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"CAPPS investigators. Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1665-2681(19)32153-2","article-title":"Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy","volume":"2","author":"Vaquero","year":"2003","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2003.12.007","article-title":"Infection, inflammation, and hepatic encephalopathy, synergism redefined","volume":"40","author":"Blei","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2007.03.026","article-title":"Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetized with pentobarbital","volume":"47","author":"Pedersen","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-8278(00)80185-3","article-title":"Enhanced monocyte activation and hepatotoxicity in response to endotoxin in portal hypertension","volume":"32","author":"Perez del Pulgar","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.1840080207","article-title":"Endotoxin levels measured by a chromogenic assay in portal, hepatic, and peripheral blood in patients with cirrhosis","volume":"8","author":"Lumsden","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.24751","article-title":"Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis","volume":"55","author":"Kalambokis","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.009_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bpg.2003.10.005","article-title":"Gut microflora in the pathogenesis of the complications of cirrhosis","volume":"18","author":"Garcia-Tsao","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mehy.2010.08.043","article-title":"Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could simple antibiotics raise blood counts?","volume":"76","author":"Kalambokis","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cld.2012.03.009_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2011.02650.x","article-title":"Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia","volume":"32","author":"Kalambokis","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2012.03.009_bib45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2141.1979.tb01171.x","article-title":"Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinemic states","volume":"42","author":"McGrath","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cld.2012.03.009_bib46","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/jhep.2003.50209","article-title":"A\u00a0role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis","volume":"37","author":"Kajihara","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","article-title":"Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis","volume":"109","author":"Violi","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.009_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V83.1.152.152","article-title":"Effect of human recombinant cytokines on the induction of macrophages procoagulant activity","volume":"83","author":"Schwager","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cld.2012.03.009_bib49","first-page":"569","article-title":"Hepatic encephalopathy","volume":"vol. 1","author":"Cordoba","year":"2007"},{"key":"10.1016\/j.cld.2012.03.009_bib50","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ajg.2009.160","article-title":"Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy","volume":"104","author":"Hassanein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042737-200012020-00012","article-title":"Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study","volume":"12","author":"Williams","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic-encephalopathy: a double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.009_bib53","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1011610427843","article-title":"Quality of life in cirrhotics with minimal hepatic encephalopathy","volume":"16","author":"Schomerus","year":"2001","journal-title":"Metab Brain Dis"},{"issue":"12","key":"10.1016\/j.cld.2012.03.009_bib55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncpgasthep0999","article-title":"Minimal hepatic encephalopathy","volume":"4","author":"Stewart","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2012.03.009_bib56","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.1996.00550080076015","article-title":"Neuropsychological characterization and detection of subclinical hepatic encephalopathy","volume":"53","author":"McCrea","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cld.2012.03.009_bib57","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neurophysiological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2007-1007244","article-title":"Subclinical hepatic encephalopathy","volume":"16","author":"Quero","year":"1996","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.03.009_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.22373","article-title":"The need for better clinical trials","volume":"48","author":"Kamath","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib60","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.21515","article-title":"Testing for minimal hepatic encephalopathy in the United States: an AASLD survey","volume":"45","author":"Bajaj","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib61","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy","volume":"96","author":"Blei","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2012.03.009_bib62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199708143370707","article-title":"Treatment of hepatic encephalopathy","volume":"337","author":"Riordan","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.03.009_bib63","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.mcna.2008.03.009","article-title":"Hepatic encephalopathy","volume":"92","author":"Munoz","year":"2008","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cld.2012.03.009_bib64","first-page":"6","article-title":"Hepatic encephalopathy: are NH4 levels and protein restriction obsolete?","volume":"95","author":"Caruana","year":"2011","journal-title":"Pract Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11011-007-9060-7","article-title":"The treatment of hepatic encephalopathy","volume":"22","author":"Morgan","year":"2007","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.cld.2012.03.009_bib66","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomized trials","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2012.03.009_bib67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/lt.21593","article-title":"Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation","volume":"15","author":"Sotil","year":"2009","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.03.009_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1746-6342.2006.03218.x","article-title":"Review article the current pharmacological therapies for hepatic encephalopathy","volume":"25","author":"Bass","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.03.009_bib69","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.510260606","article-title":"Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy","volume":"26","author":"Watanabe","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2012.03.009_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (The RIME Trial)","volume":"106","author":"Sidhu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib71","first-page":"S74","article-title":"Functional core modulation following treatment of minimal hepatic encephalopathy with l-ornithine l-aspartate: a potential novel mechanism of action","volume":"54","author":"Mcphail","year":"2011","journal-title":"46th annual meeting of the european-association-for-the-study-of-the-liver (EASL)"},{"key":"10.1016\/j.cld.2012.03.009_bib72","first-page":"683","article-title":"Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad","volume":"59","author":"Devrajani","year":"2009","journal-title":"J\u00a0Pak Med Assoc"},{"key":"10.1016\/j.cld.2012.03.009_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1665-2681(19)32157-X","article-title":"Bacterial infections associated with\u00a0hepatic encephalopathy: prevalence and outcome","volume":"2","author":"Strauss","year":"2003","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1443-1661.2005.00426.x","article-title":"Endoscopic coagulation therapy is successful for improving encephalopathy in cirrhotic patients with gastric antral vascular ectasia","volume":"17","author":"Zushi","year":"2005","journal-title":"Dig Endosc"},{"key":"10.1016\/j.cld.2012.03.009_bib75","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/gut.52.7.1041","article-title":"Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver","volume":"52","author":"Jalan","year":"2003","journal-title":"Gut"},{"issue":"Supp 1","key":"10.1016\/j.cld.2012.03.009_bib76","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0168-8278(09)60107-0","article-title":"Phase 2, multicenter, randomized study of AST-120 (spherical carbon adsorbent) vs. lactulose in the treatment of low-grade hepatic encephalopathy","volume":"50","author":"Pockros","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hep.510310107","article-title":"Partial pressure of ammonia versus ammonia in hepatic encephalopathy","volume":"31","author":"Kramer","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib78","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","article-title":"Correlation between ammonia levels and the severity of hepatic encephalopathy","volume":"114","author":"Ong","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2012.03.009_bib79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.46.6.849","article-title":"Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration","volume":"46","author":"Plauth","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.03.009_bib80","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/gast.2003.50062","article-title":"Liver transplantation improves hepatic myelopathy: evidence by three cases","volume":"124","author":"Weissenborn","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.009_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044.pub2","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","volume":"2","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2012.03.009_bib82","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: an open label randomized controlled trial of lactulose versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2012.03.009_bib83","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/ajg.2011.182","article-title":"Lactulose: how many ways can one drug be prescribed?","volume":"106","author":"Lukers","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 9","key":"10.1016\/j.cld.2012.03.009_bib84","first-page":"1","article-title":"Treatment of patients with hepatic encephalopathy: review of the latest data from EASL 2011","volume":"7","author":"Bass","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib85","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MEG.0b013e328330a8d3","article-title":"Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy","volume":"22","author":"Malaguarnera","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.20481","article-title":"Dietary fiber decreases ammonia levels in patients with cirrhosis","volume":"41","author":"Iwasa","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib87","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal\u00a0hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib88","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3748\/wjg.v16.i27.3347","article-title":"Changing face of hepatic encephalopathy: role of inflammation and oxidative stress","volume":"16","author":"Seyan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.009_bib89","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1542-3565(04)00667-6","article-title":"A\u00a0randomized controlled trial of acarbose in hepatic encephalopathy","volume":"3","author":"Gentile","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14787210.3.2.201","article-title":"Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections","volume":"3","author":"Gerard","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.03.009_bib91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: in\u00a0vitro and in\u00a0vivo antibacterial activity \u2013 a review","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cld.2012.03.009_bib92","first-page":"186","article-title":"Effects of rifaximin on bacterial virulence mechanisms at supra-and sub-inhibitory concentrations","volume":"20","author":"Debbia","year":"2008","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.cld.2012.03.009_bib93","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2036.2011.04808.x","article-title":"Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy \u2013 a double-blind placebo-controlled study","volume":"34","author":"Sanyal","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.03.009_bib94","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0168-8278(10)60017-7","article-title":"Rifaximin treatment improved quality of life in patients with hepatic encephalopathy: results of a large, randomized, placebo-controlled trial","volume":"52","author":"Sanyal","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib95","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6 Suppl 9","key":"10.1016\/j.cld.2012.03.009_bib96","first-page":"1","article-title":"Long term efficacy and survival in patients treated with the gut-selective antibiotic rifaximin (550 mg BID) for the maintenance of remission from overt hepatic encephalopathy","volume":"7","author":"Mullen","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib97","first-page":"328A","article-title":"Long-term administration of rifaximin improves the prognosis of patients with alcohol-related decompensated cirrhosis: a case-control study","volume":"52","author":"Vlachogiannakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib98","first-page":"331A","article-title":"Impact of rifaximin treatment on survival in patients with end-stage liver disease","volume":"52","author":"Leise","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.03.009_bib99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2710.2009.01120.x","article-title":"Naloxone in the management of hepatic encephalopathy","volume":"35","author":"Jiang","year":"2010","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.cld.2012.03.009_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002798.pub2","article-title":"Benzodiazepine receptor antagonists for hepatic encephalopathy","volume":"2","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2012.03.009_bib101","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","article-title":"Normal protein diet for episodic hepatic encephalopathy: results of a randomized study","volume":"41","author":"Cordoba","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2012.03.009_bib102","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: the modern management of hepatic encephalopathy","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"6 Suppl 9","key":"10.1016\/j.cld.2012.03.009_bib103","first-page":"1","article-title":"Chronic hepatic encephalopathy (HE) in patients with severe liver cirrhosis: efficacy of the wheat and milk protein free diet in the reduction of clinical episodes","volume":"7","author":"Balzola","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib104","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1365-2036.2010.04448.x","article-title":"Clinical trial: oral zinc in hepatic encephalopathy","volume":"32","author":"Takuma","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.03.009_bib105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1746.2008.05582.x","article-title":"L-ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis","volume":"24","author":"Jiang","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.03.009_bib106","series-title":"Ocera therapeutics completes first in human studies with OCR-002 for the treatment of hyperammonemia and hepatic encephalopathy","year":"2010"},{"key":"10.1016\/j.cld.2012.03.009_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001939","article-title":"Branched-chain amino acids for hepatic encephalopathy","volume":"2","author":"Als-Nielsen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2012.03.009_bib108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","article-title":"Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial","volume":"26","author":"Malaguarnera","year":"2011","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.cld.2012.03.009_bib109","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.009_bib110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2012.03.009_bib111","first-page":"482","article-title":"Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial","volume":"104","author":"Kanematsu","year":"1988","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.cld.2012.03.009_bib112","first-page":"1057","article-title":"Is the intestinal lavage with a solution of mannitol effective in the prevention of post-hemorrhagic hepatic encephalopathy in patients with liver cirrhosis? Results of a randomized prospective study","volume":"18","author":"Rolachon","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"10.1016\/j.cld.2012.03.009_bib113","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.1840070404","article-title":"Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial","volume":"7","author":"Uribe","year":"1987","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.009_bib114","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","article-title":"Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study","volume":"25","author":"Kircheis","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.009_bib115","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(98)80237-7","article-title":"Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study","volume":"28","author":"Stauch","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.009_bib116","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.1840160123","article-title":"Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial","volume":"16","author":"Sushma","year":"1992","journal-title":"Hepatology"},{"issue":"8401","key":"10.1016\/j.cld.2012.03.009_bib117","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(84)92567-4","article-title":"Oral zinc supplementation improves hepatic encephalopathy. Results of a randomized controlled trial","volume":"2","author":"Reding","year":"1984","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cld.2012.03.009_bib118","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/BF01307509","article-title":"Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial","volume":"36","author":"Riggio","year":"1991","journal-title":"Dig Dis Sci"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611200027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611200027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T15:43:51Z","timestamp":1594050231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932611200027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S108932611200027X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.03.009","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}